130 results
Page 5 of 7
F-4
nly6p
15 Jun 21
Registration of securities (foreign)
12:00am
424B3
g5ygxarnqfpm 5y
7 Jun 21
Prospectus supplement
9:16am
424B3
jwozbx6 ol7j8s
7 Jun 21
Prospectus supplement
9:16am
6-K
EX-99.1
76iixg15s v7x
7 Jun 21
FDA confirms NDA for Oleogel-S10 will not require an Advisory Committee Meeting
9:13am
424B3
cjvn7871a592ahz
3 Jun 21
Prospectus supplement
6:06am
424B3
jjf3rq8f q8bd1
3 Jun 21
Prospectus supplement
6:06am
6-K
EX-99.1
r0u0qs42wl20h e3
3 Jun 21
FDA Grants Priority Review for New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
6:03am
424B3
yqy541q7yfkpxf84ajt
2 Jun 21
Prospectus supplement
10:10am
424B3
4p3 vxy3zu8yk
2 Jun 21
Prospectus supplement
10:09am
424B3
nqtp1d0sgl14up3od
2 Jun 21
Prospectus supplement
10:08am
6-K
EX-99.1
61s 1iq61pvlxi
2 Jun 21
Amryt Announces FDA Acceptance of New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
9:02am
425
v9rspd9 wqeka9xfr9
5 May 21
Business combination disclosure
5:27pm
425
1p1nj
5 May 21
Business combination disclosure
5:26pm
425
l7v8he s78thb
5 May 21
Business combination disclosure
5:24pm
6-K
9urr31l
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
y7jxro o3t9u3y
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.5
8nelvui7
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
vdx7b8 hyl
5 May 21
Amryt Reports Record Q1 2021 Financial and Operating Results
9:40am
6-K
EX-99.1
c21g5p0f4tvr2fu
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
11y9f455vmd5yjpnfr9w
30 Apr 21
Annual report (foreign)
12:53pm